Bulletin
Investor Alert

New York Markets After Hours

BioLine RX Ltd. ADR

NAS: BLRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206459058/composite

$

1.56

Change

0.00 0.00%

Volume

Volume 1

Sep 25, 2020, 4:03 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206459058/composite

Today's close

$ 1.64

$ 1.56

Change

-0.08 -4.88%

Day low

Day high

$1.56

$1.64

Open
Open: 1.64

52 week low

52 week high

$1.06

$3.04

Open

Market cap

$32.32M

Average volume

369,536

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.40

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/blrx

MarketWatch News on BLRX

  1. BioLine RX started at outperform with $3 stock price target at Oppenheimer

    8:21 a.m. Aug. 4, 2017

    - Tomi Kilgore

  2. BioLine RX stock price target cut to $1 from $4 at Maxim Group

    7:23 a.m. Aug. 12, 2016

    - Tomi Kilgore

  3. Cancer Therapy May See Major Shift

    8:34 a.m. March 17, 2016

    - Barron's Online

  4. Darden shares rise after earnings beat

    7:38 p.m. Dec. 16, 2014

    - Wallace Witkowski

  5. BioLineRx's stock soars 17% premarket after collaboration pact with Novartis Pharma

    8:13 a.m. Dec. 16, 2014

    - Tomi Kilgore

  6. Three Biotechs Ready to Partner Up

    10:30 a.m. Sept. 8, 2014

    - Barron's Online

  7. Monday’s biggest gaining and declining stocks

    6:41 p.m. Sept. 25, 2012

    - Greg Morcroft

  8. Tuesday’s biggest gaining and declining stocks

    5:09 p.m. Sept. 25, 2012

    - Greg Morcroft

  9. Stocks to Watch Wednesday: Jabil Circuit

    4:37 p.m. Sept. 25, 2012

    - David B. Wilkerson

  10. Vertex to advance testing of oral HCV drug regimen

    10:34 a.m. Sept. 25, 2012

    - Val Brickates Kennedy

  11. BioLine up 16% on schizophrenia patent move

    9:21 a.m. Sept. 24, 2012

    - Steve Gelsi

  12. BioLine RX rallies 15% in premarket

    9:10 a.m. Sept. 24, 2012

    - Steve Gelsi

  13. BioLine gets U.S. patent for schizophrenia drug

    8:54 a.m. Sept. 24, 2012

    - Greg Morcroft

  14. BioLine RX shares jump 36%

    8:52 a.m. Sept. 24, 2012

    - Greg Morcroft

  15. Achillion, Idenix move on price target changes

    10:29 a.m. Sept. 19, 2012

    - Val Brickates Kennedy

  16. Idenix plunges 30% on HCV drug setback

    12:56 p.m. Aug. 16, 2012

    - Val Brickates Kennedy

  17. Monday’s biggest gaining and declining stocks

    4:12 p.m. Aug. 13, 2012

    - MarketWatch

  18. Achillion's chief medical officer resigns

    4:19 p.m. June 6, 2012

    - Val Brickates Kennedy

  19. Tuesday’s biggest gaining and declining stocks

    4:49 p.m. June 5, 2012

    - MarketWatch

  20. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/blrx

Other News on BLRX

  1. Savara to Stop Study on Molgradex for NTM Lung Infection

    12:47 p.m. Sept. 4, 2020

    - Zacks.com

  2. BioLineRx advances late-stage study of motixafortide

    9:09 a.m. Aug. 19, 2020

    - Seeking Alpha

  3. Avenue Therapeutics (ATXI) Misses Earnings Estimates in Q2

    10:33 a.m. Aug. 17, 2020

    - Zacks.com

  4. Catalyst's (CPRX) Q2 Earnings & Revenues Beat Estimates

    8:44 a.m. Aug. 11, 2020

    - Zacks.com

  5. Biolinerx (BLRX) Gets a Buy Rating from Oppenheimer

    6:30 p.m. Aug. 6, 2020

    - SmarterAnalyst

  6. H.C. Wainwright Sticks to Its Buy Rating for Biolinerx (BLRX)

    12:40 p.m. Aug. 6, 2020

    - SmarterAnalyst

  7. Bet on Rising Price-to-Earnings With 5 Top Stocks

    7:01 a.m. July 10, 2020

    - Zacks.com

  8. Aclaris (ACRS) Surges: Stock Moves 5.4% Higher

    8:43 a.m. July 8, 2020

    - Zacks.com

  9. Acceleron (XLRN) in Focus: Stock Moves 5.3% Higher

    8:50 a.m. July 6, 2020

    - Zacks.com

  10. Zogenix (ZGNX) in Focus: Stock Moves 7.6% Higher

    8:53 a.m. July 2, 2020

    - Zacks.com

  11. Loading more headlines...
/news/pressrelease/company/us/blrx

Press Releases on BLRX

  1. BioLineRx to Report Second Quarter 2020 Results on August 6, 2020

    9:35 a.m. Aug. 3, 2020

    - PR Newswire - PRF

  2. BioLineRx Announces $4.39 Million Registered Direct Offering

    8:00 a.m. June 1, 2020

    - PR Newswire - PRF

  3. BioLineRx Announces $9.0 Million Registered Direct Offering

    8:40 a.m. May 26, 2020

    - PR Newswire - PRF

  4. BioLineRx to Report First Quarter 2020 Results on May 20, 2020

    7:00 a.m. May 15, 2020

    - PR Newswire - PRF

  5. BioLineRx Ltd. to Host Earnings Call

    8:02 a.m. March 12, 2020

    - ACCESSWIRE

  6. BioLineRx to Report Annual 2019 Results on March 12, 2020

    9:00 a.m. March 6, 2020

    - PR Newswire - PRF

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.